These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 998618)

  • 61. Utility of new red cell parameters for distinguishing functional iron deficiency from absolute iron deficiency in children with familial Mediterranean fever.
    Gezgin Yıldırım D; Kaya Z; Bakkaloglu SA
    Int J Lab Hematol; 2019 Apr; 41(2):293-297. PubMed ID: 30624866
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.
    Duzova A; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bassoy Y; Yilmaz E
    Clin Exp Rheumatol; 2003; 21(4):509-14. PubMed ID: 12942707
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Continuity of cytokine activation in patients with familial Mediterranean fever.
    Bagci S; Toy B; Tuzun A; Ates Y; Aslan M; Inal A; Gulsen M; Karaeren N; Dagalp K
    Clin Rheumatol; 2004 Aug; 23(4):333-7. PubMed ID: 15293095
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The importance of serial measurements of cytokine levels for the evaluation of their role in pathogenesis in familial Mediterraean fever.
    Akcan Y; Bayraktar Y; Arslan S; Van Thiel DH; Zerrin BC; Yildiz O
    Eur J Med Res; 2003 Jul; 8(7):304-6. PubMed ID: 12911867
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum 17-OH progesterone and free testosterone levels in women patients with Familial Mediterranean Fever: a pivotal study.
    Deveci K; Gokakin AK; Boztosun A; Deveci H; Senel S; Uslu AU; Sancakdar E
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):261-5. PubMed ID: 23377818
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increased psoriasis frequency in patients with familial Mediterranean fever.
    Erden A; Batu ED; Seyhoğlu E; Sari A; Sönmez HE; Armagan B; Demir S; Bilgin E; Kilic L; Karadag O; Akdogan A; Bilginer Y; Ertenli I; Kiraz S; Apras Bilgen S; Kalyoncu U
    Ups J Med Sci; 2018 Mar; 123(1):57-61. PubMed ID: 29363386
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tumor markers in familial Mediterranean fever and their correlation with the frequency of attacks.
    Balaban YH; Simsek H; Yilmaz R; Sarer-Yurekli BP; Shorbagi A; Tatar G
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S114-6. PubMed ID: 19026128
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study.
    Karakurt Arıtürk Ö; Üreten K; Sarı M; Yazıhan N; Ermiş E; Ergüder İ
    Anadolu Kardiyol Derg; 2013 Jun; 13(4):357-62. PubMed ID: 23531873
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-neutrophil cytoplasmic antibodies in familial Mediterranean fever.
    Simsek H; Kadayifci A; Kirazli S
    Clin Rheumatol; 1996 Mar; 15(2):216-8. PubMed ID: 8777864
    [No Abstract]   [Full Text] [Related]  

  • 71. Evaluation of platelet indices in children with familial Mediterranean fever: confounding factors should be considered.
    Varol E
    Rheumatol Int; 2014 Aug; 34(8):1185-6. PubMed ID: 24553679
    [No Abstract]   [Full Text] [Related]  

  • 72. Vascular risk in familial Mediterranean fever.
    Rodríguez AJ
    Anatol J Cardiol; 2017 Feb; 17(2):139. PubMed ID: 27488760
    [No Abstract]   [Full Text] [Related]  

  • 73. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever.
    Simsek I; Pay S; Pekel A; Dinc A; Musabak U; Erdem H; Sengul A
    Rheumatol Int; 2007 Jul; 27(9):807-11. PubMed ID: 17225924
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers.
    Ehrenfeld M; Levy M; Bar Eli M; Gallily R; Eliakim M
    Br J Clin Pharmacol; 1980 Sep; 10(3):297-300. PubMed ID: 7437248
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correction of a suppressor cell deficiency in familial Mediterranean fever by colchicine.
    Ilfeld D; Weil S; Kuperman O
    Clin Exp Immunol; 1981 Oct; 46(1):77-81. PubMed ID: 6461454
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The immune system in familial Mediterranean fever.
    Melamed I; Shemer Y; Zakuth V; Tzehoval E; Pras M; Spirer Z
    Clin Exp Immunol; 1983 Sep; 53(3):659-62. PubMed ID: 6225577
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circulating hydroxy fatty acids in familial Mediterranean fever.
    Aisen PS; Haines KA; Given W; Abramson SB; Pras M; Serhan C; Hamberg M; Samuelsson B; Weissmann G
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1232-6. PubMed ID: 3919389
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhanced neutrophil chemiluminescence in familial Mediterranean fever.
    Anton PA; Targan SR; Vigna SR; Durham M; Schwabe AD; Shanahan F
    J Clin Immunol; 1988 Mar; 8(2):148-56. PubMed ID: 3372691
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hyper-IGD syndrome: a new case treated with colchicine.
    Ostuni PA; Lazzarin P; Ongaro G; Gusi R; Todesco S; Gambari PF
    Clin Rheumatol; 1988 Sep; 7(3):398-401. PubMed ID: 3229086
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Familial Mediterranean fever. Recent advances in pathogenesis and management.
    Schwabe AD; Terasaki PI; Barnett EV; Territo MC; Klinenberg JR; Peters RS
    West J Med; 1977 Jul; 127(1):15-23. PubMed ID: 878470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.